Company that has developed a treatment to solve mobility issues for patients with knee osteoarthritis
ArthroSave has raised €2.6M across 1 funding round from 2 investors, most recently a round in Jan 2023. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-09 | Other | €2.6M |
| Essential Investments,Oost NL |
| View deal → |
